Discontinuation report LIVOSTIN SUS NAS 0.5MG/ML

Last updated on 2021-01-13 History
Report ID 117970
Drug Identification Number 02020017
Brand name LIVOSTIN SUS NAS 0.5MG/ML
Common or Proper name LIVOSTIN
Company Name JANSSEN INC
Market Status MARKETED
Active Ingredient(s) LEVOCABASTINE
Strength(s) 0.05MG
Dosage form(s) SUSPENSION SPRAY
Route of administration NASAL NASAL
Packaging size 1x1
ATC code R01AC
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-01-01
Actual discontinuation date 2021-01-12
Remaining supply date 2020-12-24
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 19 GREEN BELT DRIVE
TORONTO, ONTARIO
CANADA M3C 1L9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-06-16 English Compare
v2 2020-06-16 French Compare
v3 2020-12-03 English Compare
v4 2020-12-03 French Compare
v5 2021-01-12 English Compare
v6 2021-01-12 French Compare
v7 2021-01-13 French Compare